News
-
-
PRESS RELEASE
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
Transgene and BioInvent's BT-001 oncolytic virus in combination with pembrolizumab shows positive antitumoral activity in refractory tumors. Exciting clinical data presented at ESMO 2025 -
PRESS RELEASE
Tocvan Advances Drilling, Trenching, and Pilot Mine Preparation, Mobilizing Equipment to North and South Blocks at Gran Pilar Gold-Silver Project
Tocvan Ventures Corp. mobilizes equipment for Gran Pilar Gold-Silver Project in Mexico, advancing exploration and preparing for drilling and pilot mine operation -
-
PRESS RELEASE
Capital B confirms the acquisition of 6 BTC for EUR0.6 million, the holding of a total of 2,818 BTC, and a BTC Yield of 1,657.7% YTD
Capital B confirms final completion of a €0.6 million capital increase at €1.18 per share, acquiring 6 BTC. Temporary suspension of capital program with TOBAM. Group holds 2,818 BTC valued at €262.7 million -
-
-
PRESS RELEASE
E+S Rück anticipates a stable market environment in Germany for 2026 and continued growth in demand for reinsurance protection
E+S Rück anticipates stable market environment in Germany for 2026, with continued growth in demand for reinsurance protection. Full range of innovative solutions offered -
-
PRESS RELEASE
2025 Q3 Sales: Revenue of €6.1 Billion, Stable on an Organic Basis. Strong Financial Discipline. 2025 Guidance Confirmed
FORVIA reports stable organic sales of €6.1 billion in Q3 2025, strong financial discipline, and confirms 2025 guidance. Focus on efficiency measures and debt profile improvement
